NorthStar's Radiopharmaceutical CDMO/CMO services span the spectrum of radioisotope drug development, from research and scale-up through commercialization. Radiopharmaceutical CDMO/CMO The radiopharmaceutical sector, both here in Canada and globally, is seeing significant growth, with the global market for nuclear
Radiopharmaceuticals are drugs that contain radioactive isotopes linked to targeting molecules. They emit radiation that can be detected by imaging systems (for Radiopharmaceutical CDMO/CMO Services Market Analysis and
The Cyclotron Facility & Nuclear Pharmacy provides PET isotopes, radiochemicals, radiotracers and radiopharmaceuticals to the (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is proud to announce strategic collaborations with RLS
Radiopharmaceutical CDMO/CMO Services Market Size is valued at USD 2.9 Billion in 2024 and is predicted to reach USD 7.0 Billion by the year The intricate nature of radiopharmaceutical manufacturing, coupled with stringent regulatory requirements, has led to a surge in demand for Nucleus RadioPharma July 2024 Webinar
In this episode of Talk Radioisotopes, hosts Scott and Sarah welcome Bruno Paquin, CEO of AtomVie Global Radiopharma. Radiopharm Theranostics (RAD) investor update webinar
Watch this webinar to learn about how the DRIVE-MRT solution enables the rationalization, design and optimization of targeted This video highlights the collaboration and expertise involved with the creation of the first radiopharmaceutical manufacturing Did you miss us live? This webinar is now available on demand. “What should providers and patients know about
Multimodal approaches to the delivery of radiologically active compounds have created a fertile environment to for players in the Join the Nucleus RadioPharma Team - Quality System Manager Position Open Nucleus RadioPharma October 2024 Webinar
Bruno Paquin, CTO, AtomVie Global Radiopharma - Benefits and Challenges of Radiopharmaceuticals Radiopharmaceuticals market in next five years #podcast #talkradioisotopes
A Look Back At The 2025 SNMMI Annual Meeting With AtomVie Global Radiopharma Angstrom Technology helped a customer working in advanced radiopharmaceuticals research and development design and
Radiopharmaceutical Drug Development in Canada In this segment of the Outsourced Pharma Live virtual event A New Age For Small Molecule Development, Conrad Wüllerm MSc, NorthStar medical Radioisotopes hosts grand opening of new facility
Evergreen Theragnostics: Design & Construction of State-of-the-Art Radiopharmaceutical Facility A presentation by Dr Esther Schirrmacher This short course is designed to give an overview of GMP in Radiopharmaceutical
Cyclotron Facility & Nuclear Pharmacy Virtual Tour Presenter: Bruno Paquin Title: CTO Company: AtomVie Global Radiopharma Presentation: Benefits and Challenges of NorthStar Medical Radioisotopes unveiled its new state-of-the-art radiopharmaceutical Contract Development & Manufacturing
During the Grand Opening of our Wilmington, MA facility, Dr. Lutz Helmke and Jay Simon took some time to tour the premises and Advanced Radiopharmaceuticals Cleanroom
In today's newsletter: - Tennis superstar #serenawilliams is partnering with #Ro to share her #glp1 story. - The UK government's Welcome to our channel, where news and job opportunities are brought to life! Our goal is to help job seekers to better understand Serena Williams shares her GLP-1 story in new role at Ro - NEWS 25/8/2025
Evergreen Theragnostics - Aerial Facility Video Join the Nucleus RadioPharma team as they answer a trending question: “What does Novartis's pursuit of a label expansion for
AtomVie | Global Radiopharma Recorded December 19, 2023 Organized by Nusano, this virtual key opinion leader (KOL) event focuses on the future of the Lab 2 Radiopharmaceutical kit preparation
Take a look back at AtomVie's booth at the 2025 SNMMI Annual Meeting where we had an incredible experience connecting with Importance of Just in Time Delivery for Radiopharmaceuticals
Radiopharmaceutical CDMO Market Explained | Nuclear Pharmacy On the Talk Radioisotopes podcast, Jeff Jones of Oppenheimer & Company discusses the latest trends in the radiopharmaceutical CDMO Services. Leverage our network of experts to bring your radiopharmaceutical candidate from preclinical development to commercial launch.
Radiopharmaceutical CDMO Market Explained Nucleus RadioPharma offers premier full-service CDMO services to accelerate your radiopharmaceutical from research to market swiftly and safely.
A short video from SCW for Pharma Podcast Series Episode 7 with Indranil Nandi, Chief Scientific Officer at Jubilant Radiopharma CANM Radiopharmacy Course GMP in Radiopharmaceutical Production CDMO Services For Targeted Radiotherapies | Nucleus RadioPharma
Radiopharmaceutical CDMO Market Explained - PharmaSource Radiopharmaceutical CDMO Market Major players are improving growth by investing in more efficient manufacturing systems, ecological design, and Jubilant Pharmova Limited
Evergreen Theragnostics was established in 2019 to be a leading US-based radiopharmaceutical Contract Development and Finding CDMO Capacity In Radiopharmaceutical Drug Development
Evergreen Virtual Facility Tour 2023 Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with a global presence that is involved in The market is projected to reach $5.44 Billion USD by 2031, growing from USD 2.75 billion in 2023 (source). This represents a robust compound annual growth
[webinar] Establishing an Expert Network for Your Radiopharmaceutical Drug Development Program Nucleus RadioPharma: Full-Service CDMO For Targeted
Episode 4 - Bruno Paquin, CEO of AtomVie Global Radiopharma Research & Development Eckert & Ziegler's Boston Area Facility for Radiopharmaceutical Production and CDMO Work
Our radiopharmaceutical CDMO services support your drug from early development to commercial production, ensuring speed, efficiency, and regulatory compliance. [Latest] Global Radiopharmaceutical CDMO Market Size/Share Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.
Webinar: Emerging Trends in Radiotherapeutics